Workshop on Synthetic Biology, 18-19 March 2010, Brussels - Final programme available
Workshop on Synthetic Biology:
From Science to Governance
18-19 March 2010, Brussels
Venue: Sofitel Hotel, Place Jourdan, Brussels
On 18-19 March 2010, the European Commission's Directorate General for Health and Consumers (DG SANCO) is organising in Brussels a Workshop on synthetic biology.
Synthetic biology is an exciting emerging field of research with rapid development and promising applications. Given its multidisciplinary nature and its wide-ranging potential impact on society, synthetic biology raises a number of social, ethical and regulatory questions which need to be addressed in a timely manner.
The aim of this Workshop is to provide a clear overview of existing developments and to try to foresee the likely time-scale of future applications. Furthermore, it will be a good opportunity to discuss the main challenges (in governance, social, ethical and legal issues) facing the field of synthetic biology as well as the possible approaches for tackling these challenges.
Programme of the Workshop
Proceedings of the Workshop
Presentations at the Workshop
- Synthetic Biology – State, Importance and Development
R. I Kitney
Imperial College, UK - Synthetic Biology activities in the Knowledge Based Bioeconomy
I. Economidis
European Commission - DG Research - Foundations for a European SynBio
T. Reiss/S. Gaisser
Fraunhofer institute for Systems and Innovation - Applications in SynBio: Present and Future
H. Bernauer
International Association Synthetic Biology (IASB) - Synthetic Biology present & future - a view from Genopole
F. Képès/F. Russo-Marie
Genopole - Turning the promise of synthetic biology into commercial reality for health and energy
J. R. Cherry
Amyris Biotechnologies Inc. - Energy Biosciences Institute - Linking Biotechnology and Energy
P. Willems
Energy Biosciences Institute - Synthetic Biology in Food & Health
V. Martins dos Santos
Helmholtz Centre for Infection Research (HZI) - SynBio for the Environment
V. de Lorenzo
Centro Nacional de Biotecnología (CSIC) , Madrid - Synthetic Biology in Drug Discovery and Combating Drug Resistance
W. Weber
Bioss centre, Albert- Ludwigs-Univeristy Freiburg - SynBio in pharmaceuticals and update onNanomot project
S. Panke
ETH, Swiss - SynBio projects at RIKEN (and India)
P. K Dhar
RIKEN, Yokohama, Japan - Safety, ethics and governance of SynBio: concerns and challenges
G. Hermerén
European Group of Ethics (EGE) - Synthetic biology: a view from SCENIHR
J. Bridges
SCENIHR - Biosafety and Public Outreach in Synthetic Biology
M. Schmidt
Organisation for International Dialogue and Conflict Management, IDC, Austria - Why secure synthetic biology?
P. Millett
United Nations Office, Geneva (Biological Weapons Convention Implementation Support Unit) - Public Perceptions On the Technological Frontier: The Case of Synthetic Biology ("Synbio")
E. Pauwels
Woodrow Wilson International Center for Scholars - Patent issues in SynBio applications
B. Rutz
European Patent Office - Risk Governance of Synthetic Biology: International Risk Governance Council Project
J. Tait
University of Edinburgh - Synbio Concerns: a bottom up process driven by VivAgora
D. Benoit Browaeys
VivAgora - EC Initiatives on the governance and ethics of new and emerging technologies: the case of Synthetic Biology
P. Zilgalvis
European Commission - DG Research - U.S. Initiative: Screening Framework Guidance for Synthetic Double-Stranded DNA Providers
J. Tucker
U.S. Department of Health and Human Services - SynBio Governance approaches: Lessons from nanotechnology
F. Roure
French High Council for Industry, Energy and Technologies - Governance of Social and Ethical Impacts of SynBio
D. Stemerding/F. W.A. Brom
Rathenau Institute - Synthetic Genomics Options for Governance
M. S. Garfinkel
J. Craig Venter Institute
Details
- Publication date
- 15 March 2010
- Author
- Directorate-General for Health and Food Safety